Insider Transactions in Q1 2020 at Syneos Health, Inc. (SYNH)
Insider Transaction List (Q1 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 20
2020
|
Jason M. Meggs Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
3,555
+2.64%
|
$127,980
$36.38 P/Share
|
|
Mar 19
2020
|
Paul Colvin Pres., Clinical Solutions |
BUY
Open market or private purchase
|
Direct |
1,300
+4.62%
|
$46,800
$36.65 P/Share
|
|
Mar 05
2020
|
Jason M. Meggs Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,115
+4.14%
|
-
|
|
Mar 05
2020
|
Jason M. Meggs Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,094
+6.88%
|
-
|
|
Mar 05
2020
|
Michelle Keefe Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,549
+5.98%
|
$147,686
$14.83 P/Share
|
|
Mar 05
2020
|
Alistair Macdonald Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,217
+4.47%
|
-
|
|
Mar 05
2020
|
Alistair Macdonald Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,258
+11.16%
|
-
|
|
Mar 05
2020
|
Paul Colvin Pres., Clinical Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
2,491
+7.82%
|
-
|
|
Mar 05
2020
|
Jonathan Olefson General Counsel & Corp Secty |
BUY
Grant, award, or other acquisition
|
Direct |
1,898
+6.38%
|
-
|
|
Feb 18
2020
|
Alistair Macdonald Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,451
-5.41%
|
$821,766
$66.51 P/Share
|
|
Feb 18
2020
|
Jason M. Meggs Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,680
-4.26%
|
$176,880
$66.51 P/Share
|
|
Feb 18
2020
|
Michelle Keefe Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,887
-4.12%
|
$124,542
$66.51 P/Share
|
|
Jan 27
2020
|
Jason M. Meggs Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
380
-0.6%
|
$23,560
$62.69 P/Share
|
|
Jan 27
2020
|
Alistair Macdonald Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,545
-5.56%
|
$839,790
$62.69 P/Share
|
|
Jan 19
2020
|
Alistair Macdonald Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,293
-0.53%
|
$81,459
$63.83 P/Share
|
|
Jan 19
2020
|
Jason M. Meggs Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
129
-0.2%
|
$8,127
$63.83 P/Share
|
|
Jan 17
2020
|
Robert Parks EVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,135
+20.89%
|
-
|
|
Jan 15
2020
|
Jonathan Olefson General Counsel & Corp Secty |
BUY
Grant, award, or other acquisition
|
Direct |
6,692
+20.51%
|
-
|
|
Jan 15
2020
|
Paul Colvin Pres., Clinical Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
11,862
+31.7%
|
-
|
|
Jan 15
2020
|
Jason M. Meggs Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,803
+17.86%
|
-
|
|
Jan 15
2020
|
Michelle Keefe Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,862
+20.58%
|
-
|
|
Jan 15
2020
|
Alistair Macdonald Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,770
+16.6%
|
-
|
|
Jan 08
2020
|
Jonathan Olefson General Counsel & Corp Secty |
SELL
Payment of exercise price or tax liability
|
Direct |
1,095
-5.38%
|
$64,605
$59.96 P/Share
|
|
Jan 08
2020
|
Alistair Macdonald Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,155
-4.92%
|
$599,145
$59.96 P/Share
|
|
Jan 08
2020
|
Michelle Keefe Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,559
-4.39%
|
$91,981
$59.96 P/Share
|
|
Jan 08
2020
|
Robert Parks EVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
679
-5.56%
|
$40,061
$59.96 P/Share
|
|
Jan 08
2020
|
Paul Colvin Pres., Clinical Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
1,404
-9.3%
|
$82,836
$59.96 P/Share
|
|
Jan 08
2020
|
Jason M. Meggs Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,732
-3.37%
|
$102,188
$59.96 P/Share
|
|
Jan 02
2020
|
Paul Colvin Pres., Clinical Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
249
-1.62%
|
$14,691
$59.51 P/Share
|